Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
about
Alcohol, aldehydes, adducts and airwaysAcrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophagesElevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study.β2-Adrenoceptor involved in smoking-induced airway mucus hypersecretion through β-arrestin-dependent signaling.Airway mucus function and dysfunction.Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expressionAcrolein induces endoplasmic reticulum stress and causes airspace enlargement.An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary diseaseADAM17 mediates MMP9 expression in lung epithelial cells.Electrophilic fatty acids regulate matrix metalloproteinase activity and expression.COPD: balancing oxidants and antioxidants.Vanadium pentoxide (V(2)O(5)) induced mucin production by airway epitheliumFunctional genomics of chlorine-induced acute lung injury in mice.Haplotype association mapping of acute lung injury in mice implicates activin a receptor, type 1Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling.Effects of second hand smoke on airway secretion and mucociliary clearance.The role of Src kinase in macrophage-mediated inflammatory responses.Critical role of aldehydes in cigarette smoke-induced acute airway inflammation.Mucus hypersecretion in asthma: causes and effectsVariability in proteinase-antiproteinase balance, nutritional status, and quality of life in stable chronic obstructive pulmonary disease due to tobacco and nontobacco etiology.Acrolein - a pulmonary hazard.Acrolein effects in pulmonary cells: relevance to chronic obstructive pulmonary disease.Targeting mucus hypersecretion: new therapeutic opportunities for COPD?Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease?The Contribution of Small Airway Obstruction to the Pathogenesis of Chronic Obstructive Pulmonary Disease.Cigarette smoke extract regulates cytosolic phospholipase A2 expression via NADPH oxidase/MAPKs/AP-1 and p300 in human tracheal smooth muscle cells.Endothelial dysfunction and claudin 5 regulation during acrolein-induced lung injury.The Effect of Doxycycline on PMA-Induced MUC5B Expression via MMP-9 and p38 in NCI-H292 Cells.Positive feedback of the amphiregulin-EGFR-ERK pathway mediates PM2.5 from wood smoke-induced MUC5AC expression in epithelial cells.Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production.Effect of Epigallocatechin-3-Gallate on PMA-Induced MUC5B Expression in Human Airway Epithelial Cells.Mitochondrial ROS-K+ channel signaling pathway regulated secretion of human pulmonary artery endothelial cells.E-Cigarette Use Causes a Unique Innate Immune Response in the Lung Involving Increased Neutrophilic Activation and Altered Mucin Secretion.Proteomic identification of moesin upon exposure to acrolein.Inhibitors of ceramide de novo biosynthesis rescue damages induced by cigarette smoke in airways epithelia.A Potential Role for Acrolein in Neutrophil-Mediated Chronic Inflammation.Proposed Mode of Action for Acrolein Respiratory Toxicity Associated with Inhaled Tobacco Smoke.Regulation of cigarette smoke-induced mucin expression by neuregulin1β/ErbB3 signalling in human airway epithelial cells.
P2860
Q23918624-4D0F2FEB-5BB0-4BC9-98FB-F2A4617D9B8FQ28754552-BF44F119-02A7-42EB-BAD8-3FE9DE537B64Q33540363-558A25BF-C7C0-43CA-B07E-2B2C26E1BFF5Q33721324-9EEC3E82-5A9F-452E-B12F-168532001759Q33723578-A10C84AF-9126-4C99-9CCE-A0B72228BF00Q34198929-33B5D05C-3C34-4688-94E5-F25E2896A879Q34295437-4F307074-91EE-4313-A54F-96FC75E2A172Q34480287-87257D6D-FF28-4306-ACB3-06F2C7636A63Q34558156-CD45F799-924B-443C-A3C7-9BD00133296BQ34963415-FFFB7A78-DA09-42E9-B0E6-E94C8A50F2BAQ35063488-80019B17-7CD9-481E-9DED-910ED1908C85Q35087013-C9213D1B-19A6-4E81-93F2-C06513B26D1FQ35107144-AD927CFF-2387-4950-96A1-EA49287EBD9AQ35107680-D3BCBB3D-AE83-4632-9247-13E391D43A5CQ35231067-D24E73C6-16BA-4922-A931-20115B7D414FQ36192954-AA1E87AD-990B-42B2-B5A6-F62C11F91D11Q36418104-4B8C75A4-7C2F-429E-BD1A-5DD451308DE4Q36901033-E91E0B56-9034-49F7-8D39-6B486033948AQ37259129-8FD69E5D-2740-4C63-86E4-9EEC408EBD73Q37419622-465F3CDF-2CEC-40F6-ABDE-116ECC0603DCQ37945138-B0CF8494-83A8-4460-9276-0B9F8290E840Q38023560-31F79E42-B162-49A7-9F7B-8F93722A1DE5Q38217069-DA972DF8-E128-4CCF-BDA6-23E1B7074D00Q38418872-B26B84D0-9A2F-494F-A812-D5D88781E31CQ38984610-E16C22CD-86BF-4F15-A546-15528F6730C2Q39602460-A1F98759-8012-4F36-A408-06FC75ED5EBDQ39696505-E0809C38-56DC-4A1C-BA9C-335CDF8EDCC8Q40134811-5C56B702-A120-4DA4-BDD1-28A89C0BA809Q41325338-BA402497-39A1-419B-9719-32B7A927D1B9Q41830515-A2F094BC-731C-4BDE-9BC4-FF38F5DB1C83Q42555065-63BA97B5-713C-45AF-AE6B-D56016A00A81Q42716225-7D7458F3-F025-4460-BBD8-E81235998752Q47624808-30EE2E88-AF28-4E3E-B3E9-19735A0FEBDEQ47645992-AB9E76ED-1AE4-451D-8E19-734A0E754DACQ48275464-1A09F14C-8634-480F-9350-32E055727B4FQ50877434-498207FA-77C6-493B-8FEB-CAB0A8A69AB0Q51540398-C86418C2-67A7-44CA-8A8C-5A87C5F8148AQ53266866-D27ADD2E-7030-45EB-9591-889827AA237F
P2860
Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
@en
Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
@nl
type
label
Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
@en
Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
@nl
prefLabel
Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
@en
Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
@nl
P2093
P2860
P356
P1476
Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
@en
P2093
Colleen Shaver
George D Leikauf
Hitesh S Deshmukh
Jay A Nadel
Lisa M Case
Maggie Dietsch
Massimo Corradi
Michael T Borchers
Scott C Wesselkamper
Thomas R Korfhagen
P2860
P304
P356
10.1165/RCMB.2006-0339OC
P577
2007-11-15T00:00:00Z